U.S. Markets close in 1 hr 20 mins

Can-Fite BioPharma Ltd. (CANF)


NYSE MKT - NYSE MKT Delayed Price. Currency in USD
Add to watchlist
1.84+0.02 (+1.10%)
As of 12:43PM EDT. Market open.
People also watch
VBLTCNATBLRXWGBSAQXP
  • Good time to get cheap shares as 40 meetings has added potential and the word will be getting out about the pipeline
  • feels like we may get a lift off anytime now...a rip-your-face-off rally in this stock...
  • not sure what is wrong of why the stock just keeps going in one direction,am i seeing this wrong
    seems to have so many positives going for it but stock goes down.
    can someone comment to maybe what i`m not seeing
    thanks so much?
  • bad as bad can be ...despite the potential market ignores this stock
  • It's pretty easy to notice if you follow lots of stocks. Tiny stocks like this get abused. At some point this may move even before any news.
  • All I can say is that CANF is not going to stay down for long.Just a question of when and not if, for this to go to double digits overnight.
  • 5 th failure is near..?
  • CNAT-was under 2 bucks a year ago,, now almost 10---CANF has NASH drug in Phase 2..cnat shows how valuable nash is...,,,arthritis drug in PH 3...Let er ride
  • From today's PR - "By 2025, the addressable pharmaceutical market for NASH is estimated to reach $35-40 billion."
  • Rheumatoid arthritis is a treatment market forecast to reach $34.6 billion by 2020.
  • This stock will be $4–5 by the end of June and $7 to 10 by the end of October
  • BIG DEAL TO ACQUIRE UP TO 9 MARKETED PRODUCTS IMMINENT = 2000%++ UPSIDE POTENTIAL !!!
    AQSZF (MC $15 M) is close to profitability and to file 3 NDA and the whole company is valued at ridiculous $15 Million ,this unknown stock is definitely one of the cheapest Biotech in the sector .Stock should be at minimum $2+ right now .

    Market Cap :US$ 15 Million
    Cash $4.1 Million << enough untill mid 2018
    Price 0.21

    MUST WATCH to realize the MONSTER POTENTIAL HERE
    https://www.youtube.com/watch?v=jV00WmYBtv4

    Presentation
    http://www.aequuspharma.ca/Investors/AQS%20investor%20November%202016_web.pdf

    AQS1301 topline results in 1Q 2017

    Operational profitability estimated in 2017

    File for CDN approval of Topiramate XR in 1H 2017

    File for CDN approval of Oxcarbazepine XR in 1H 2017

    Additional Product Deals in 2017

    Partnership for AQS1301 in 2017

    Two products launches to date (Tacrolimus IR and Vistitan™)

    3 long-acting, transdermal programs in development, on track to file NDA in 2018

    Aequus Pharmaceuticals
    Aequus has an expanding product pipeline of drugs in Canada. Revenues and cash flows are increasing and products produce a 50% margin, Edward Karr, Managing ...
    www.youtube.com
  • laging stock and company lets face it...failure after failure
  • I also received an alert for $CANF from http://thesubwaytrader.com/?s=CANF , any ideas? Investing day trading. White's chappagwiddick theorem: the sooner and in more detail you announce bad news

    The Subway Trader: Trading Stocks and Making Money
    Stock alerts from the The Subway Trader. Stock trading, making money and always looking for the next big money maker.
    thesubwaytrader.com
  • If this drug ever gets appt after this trial...This is a 50 dollar stock
  • The clinical trial was approved, not the drug.
    It will cost 5 million. Company has a little over 6 million in the bank.
    Will they do a secondary before they get bought out? Your guess is as good as mine, but that would be dilutive and share prices might get hurt - if and when that happens. In the meantime? Bombs away - the momo crowd has turned this into a pumpNdump 3 or 4 times in the past. I'll be waiting to hear more from the company.
  • It just can't hold onto gains unfortunately.
  • Only a 30 million market cap. Will patience be rewarded. I am betting yes.
  • I suspect will have some news in the coming days.
  • STOCK CRASHING CRASING BACK DOWN , STOCK CRASHING CRASHINBELOW $1.50 -------- 40 50 PERCENT PATIENT STOP TAKING MTX AFTER 5 YEARS BECAUSE OF SERIOUS SIDE EFFECT